Search Results - "Shaitelman, S F"

Evaluation of overall survival and barriers to surgery for patients with breast cancer treated without surgery: a National Cancer Database analysis by Boyce-Fappiano, D., Bedrosian, I., Shen, Y., Lin, H., Gjyshi, O., Yoder, A., Shaitelman, S. F., Woodward, W. A.

“…Surgery remains the foundation of curative therapy for non-metastatic breast cancer, but many patients do not undergo surgery. Evidence is limited regarding…”
Get full text

Accelerated partial-breast irradiation using intensity-modulated proton radiotherapy: do uncertainties outweigh potential benefits? by Wang, X, Zhang, X, Li, X, Amos, R A, Shaitelman, S F, Hoffman, K, Howell, R, Salehpour, M, Zhang, S X, Sun, T L, Smith, B, Tereffe, W, Perkins, G H, Buchholz, T A, Strom, E A, Woodward, W A

“…Passive scattering proton beam (PSPB) radiotherapy for accelerated partial-breast irradiation (APBI) provides superior dosimetry for APBI three-dimensional…”
Get full text

Adaptive radiotherapy for breast cancer by De-Colle, C., Kirby, A., Russell, N., Shaitelman, S.F., Currey, A., Donovan, E., Hahn, E., Han, K., Anandadas, C.N., Mahmood, F., Lorenzen, E.L., van den Bongard, D., Groot Koerkamp, M.L., Houweling, A.C., Nachbar, M., Thorwarth, D., Zips, D.

“…•Adaptive radiotherapy offers potential clinical benefits for breast cancer patients.•Advantages of MR-guided adaptive radiotherapy are expected in the…”
Get full text

Abstract ES2-3: Guiding selection of RT approach after lumpectomy by Shaitelman, SF

“…Level I evidence supports the usage of adjuvant radiation therapy following breast conserving surgery for early stage breast cancer. Historically, this was…”
Get full text

Inhibiting ATR Modulates Response to Radiation and Stimulates Immune Responses by Bright, S.J., Flint, D.B., Turner, B.X., Mandadhar, M., McFadden, C.H., Martinus, D., Kacem, M.Ben, Sawakuchi, G., Shaitelman, S.F.

“…Radiotherapy (RT) has been shown, albeit rarely, to stimulate anti-tumor immune responses. Recent evidence suggests this can, in part, be attributed to the…”
Get full text

Evaluation of Overall Survival and Barriers to Surgery for Breast Cancer Patients Treated Without Surgery by Boyce-Fappiano, D., Bedrosian, I., Shen, Y., Lin, H.Y., Gjyshi, O., Yoder, A.K., Shaitelman, S.F., Woodward, W.A.

“…Surgery remains the foundation of curative therapy for non-metastatic breast cancer, but a substantial proportion of patients do not undergo surgery. Evidence…”
Get full text

DNA Damage Response Inhibitors of DNA-PKcs, PARP, RAD51, ATR and ATM All Sensitize Cancer Cells to X-Rays and Protons by Bright, S.J., Flint, D.B., Turner, B.X., Mandadhar, M., McFadden, C.H., Martinus, D., Kacem, M.Ben, Shaitelman, S.F., Sawakuchi, G.

“…Radiotherapy (RT) controls tumors primarily by inducing DNA damage. However, some tumor cells can repair RT-induced DNA damage and are thus radioresistant. RT…”
Get full text

Prognostic Factors in Breast Cancer Patients With Clinical N3b (Ipsilateral Internal Mammary and Axillary) Disease by Andring, L.M., Diao, K., Sun, S.X., Patel, M.M., Schlembach, P.J., Arzu, I.Y., Joyner, M.M., Shaitelman, S.F., Hoffman, K.E., Stauder, M.C., Smith, B.D., Woodward, W.A.

“…Patients with clinical N3b (cN3b) breast cancer often do not undergo surgical resection of gross internal mammary (IM) nodes. Therefore, radiation is important…”
Get full text

Using NCDB for quality evaluation to assess adherence to treatment guidelines for nonmetastatic inflammatory breast cancer by Lin, H. Y., Bedrosian, I., Babiera, G., Shaitelman, S. F., Kuerer, H. M., Woodward, W., Ueno, N. T., Shen, Y.

Get full text

Optimizing Preventive Adjuvant LINAC (OPAL) Radiation: A Phase II Trial of Daily Partial Breast Irradiation by Reddy, J.P., Lei, X., Bloom, E., Reed, V.K., Schlembach, P.J., Arzu, I.Y., Gopal, R.S., Mayo, L.L., Chun, S.G., Ahmad, N.R., Stauder, M.C., Chronowski, G.M., Weed, D.W., Delclos, M.E.E., Garg, A.K., Shaitelman, S.F., Fang, P., Tereffe, W., Woodward, W.A., Smith, B.D.

“…Twice daily accelerated partial breast irradiation (APBI) may confer worse long-term cosmetic outcome than daily whole breast irradiation (WBI). We…”
Get full text

Sounding A Warning Bell? Documentation of the Increased Utilization of Accelerated Partial Breast Irradiation by Shaitelman, Simona F.

“…Whole-breast irradiation has become the standard of care following breast-conserving surgery in patients with early-stage breast cancer. Patterns of failure in…”
Get full text

Outcomes by breast cancer subtype in patients treated with accelerated partial breast irradiation by Wilkinson, J. B., Shah, C., Amin, M., Shaitelman, S. F., Nadeau, L., Chen, P., Wallace, M., Mitchell, C., Grills, I. S., Martinez, A. A., Vicini, F. A.

“…Abstract only 83 Background: To determine clinical outcomes for patients treated with accelerated partial breast irradiation (APBI) based on breast cancer…”
Get full text

Abstract OT2-04-01: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to whole breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence-free interval (IBCR-FI) in patients (pts) with pathologically positive axillary (PPAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC): NRG Oncology/NSABP B-51/RTOG 1304 by Mamounas, EP, Bandos, H, White, JR, Julian, TB, Khan, AJ, Shaitelman, SF, Torres, MA, Vicini, FA, Ganz, PA, McCloskey, SA, Paik, S, Gupta, N, Li, XA, DiCostanzo, DJ, Curran, WJ, Wolmark, N

“…This phase III post-NC trial evaluates if CWRNRT post-Mx or whole breast irradiation (WBI) with RNRT after BCS significantly reduces the IBCR-FI rate in pts…”
Get full text

Association Between Symptom Burden and Early Lymphatic Abnormalities After Regional Nodal Irradiation for Breast Cancer by Yoder, Alison K., Xu, Tianlin, Youssef, Peter, DeSnyder, Sarah, Marqueen, Kathryn E., Isales, Lynn, Lin, Ruitao, Smith, Benjamin D., Woodward, Wendy A., Stauder, Michael C., Strom, Eric A., Aldrich, Melissa B., Shaitelman, Simona F.

“…Dermal backflow visualized on near-infrared fluorescence lymphatic imaging (NIRF-LI) signals preclinical lymphedema that precedes the development of…”
Get full text

Abstract OT2-03-02: NRG oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence-free interval (IBCR-FI) in patients (pts) with positive axillary (PAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC) by Mamounas, EP, Bandos, H, White, JR, Julian, TB, Khan, AJ, Shaitelman, SF, Torres, MA, Vicini, FA, Ganz, PA, McCloskey, SA, Paik, S, Gupta, N, Li, XA, DiCostanzo, DJ, Curran, WJ, Wolmark, N

“…Background: This phase III post-NC trial evaluates if CWRNRT post-Mx or whole breast irradiation (WBI) with RNRT after BCS significantly reduces the IBCR-FI…”
Get full text

Abstract P2-11-02: Three-year outcomes with hypofractionated (HF) versus conventionally fractionated (CF) whole breast irradiation (WBI) by Shaitelman, SF, Lei, X, Thompson, A, Schlembach, P, Arzu, I, Bloom, ES, Buchholz, DJ, Chronowski, GM, Dvorak, T, Grade, EJ, Hoffman, KE, Kelly, P, Perkins, GH, Reed, V, Shah, S, Stauder, MC, Strom, EA, Tereffe, W, Woodward, WA, Baumann, D, Amaya, D, Guerra, W, Morrison, M, Hortobagyi, G, Hunt, KK, Buchholz, TA, Smith, BD

“…Background: Adoption of HF-WBI remains low due in part to concerns regarding its safety when used with a tumor bed boost or in patients who have received…”
Get full text

Abstract P2-11-12: Prospective comparison of late toxicity and cosmetic outcome after accelerated partial breast irradiation with conformal external beam radiotherapy or single-entry multi-lumen intracavitary brachytherapy by Stecklein, SR, Babiera, GV, Bedrosian, I, Shaitelman, SF, Ballo, MT, Tereffe, W, Arzu, IY, Perkins, GH, Strom, EA, Reed, VK, Dvorak, T, Smith, BD, Woodward, WA, Hoffman, KE, Schlembach, PJ, Chronowski, GM, Shah, SJ, Kirsner, SM, Nelson, CL, Guerra, W, Dibaj, SS, Bloom, ES

“…Purpose/Objective(s): To prospectively compare late toxicity after accelerated partial breast irradiation (APBI) with 3D-conformal external beam radiotherapy…”
Get full text

Abstract S3-07: Complication and economic burden of local therapy options for early breast cancer by Smith, BD, Jiang, J, Shih, Y-CT, Giordano, SH, Huo, J, Jagsi, R, Caudle, AS, Hunt, KK, Shaitelman, SF, Buchholz, TA, Shirvani, SM

“…Background: Guideline-concordant local therapy options for early breast cancer include lumpectomy plus whole breast irradiation (lump+WBI), lumpectomy plus…”
Get full text

Abstract OT2-03-01: NRG oncology/NSABP B-51/RTOG 1304: A phase III superiority clinical trial designed to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) will reduce invasive cancer events in patients (pts) with positive axillary (Ax) nodes and convert to ypN0 after neoadjuvant chemotherapy (NC) by Mamounas, EP, Bandos, H, White, JR, Julian, TB, Khan, AJ, Shaitelman, SF, Torres, MA, Vicini, FA, Ganz, PA, McCloskey, SA, Paik, S, Gupta, N, Li, XA, DiCostanzo, DJ, Curran, WJ, Wolmark, N

“…Background: This phase III post-NC trial evaluates if CWRNRT post Mx or whole breast irradiation (WBI) with RNRT after BCS significantly reduces the invasive…”
Get full text

Abstract P1-14-04: A randomized phase II neoadjuvant (NACT) study of sequential eribulin followed by FAC/FEC-regimen compared to sequential paclitaxel followed by FAC/FEC-regimen in patients (pts) with operable breast cancer not overexpressing HER-2 by Alvarez, RH, Koenig, KB, Ensor, JE, Ibrahim, NK, Chavez-MacGregor, M, Litton, JK, Schwartz Gomez, JK, Cyriac, A, Krishnamurty, S, Caudle, AS, Shaitelman, SF, Whitman, GJ, Booser, DJ, Reuben, JM, Valero, V

“…Background: Neoadjuvant chemotherapy (NACT) is an integral component for locally advanced and large operable breast cancer. The sequence of taxanes followed by…”
Get full text